Why Leifras Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket

Wendy's Company
TOP Financial Group Limited
Quoin Pharmaceuticals. Ltd Sponsored ADR
Catheter Precision, Inc.
XCHG Limited ADR

Wendy's Company

WEN

0.00

TOP Financial Group Limited

TOP

0.00

Quoin Pharmaceuticals. Ltd Sponsored ADR

QNRX

0.00

Catheter Precision, Inc.

VTAK

0.00

XCHG Limited ADR

XCH

0.00

Shares of Leifras Co Ltd (NASDAQ:LFS) rose sharply in pre-market trading after the company announced it will acquire SWIFT JAPAN for around JPY454.6 million.

Leifras shares jumped 23.2% to $2.76 in pre-market trading.

Here are some other stocks moving in pre-market trading.

Gainers

  • Megan Holdings Ltd (NASDAQ:MGN) jumped 85.2% to $0.32 in pre-market trading after gaining 30% on Tuesday. The spike follows a Securities and Exchange Commission filing on June 18, revealing the Kuala Lumpur-based company is seeking shareholder approval for a reverse stock split of up to 1-for-400 at its Jul. 13 Annual General Meeting.
  • Catheter Precision Inc (NYSE:VTAK) gained 82.6% to $1.68 in pre-market trading as investors cheered the firm’s partnership with sports and entertainment agency GSE Worldwide and a batch of newly allowed patents covering its heart failure and vascular closure technologies.
  • Cuprina Holdings (Cayman) Ltd (NASDAQ:CUPR) rose 69.2% to $6.67 in pre-market trading. Cuprina recently announced it has received 510(k) clearance from the FDA for MEDIFLY Maggots.
  • Quoin Pharmaceuticals Ltd – ADR (NASDAQ:QNRX) rose 54.5% to $5.02 in pre-market trading. Quoin Pharmaceuticals, on Tuesday, received the FDA’s conditional approval for QYLEKI to treat Netherton syndrome.
  • Churchill Capital Corp XI (NASDAQ:CCXI) gained 25.3% to $13.06 in pre-market trading.
  • Wendy’s Co (NASDAQ:WEN) jumped 19.8% to $7.49 in pre-market trading. Wendy’s, on Tuesday, appointed Steve Cirulis as CFO and chief strategy officer, succeeding Ken Cook.
  • CEA Industries Inc (NASDAQ:BNC) gained 18.5% to $2.69 in pre-market trading. YZi Labs and CEA Industries reached a cooperation agreement to strengthen BNC governance.
  • Freecast Inc (NASDAQ:CAST) gained 13.7% to $9.40 in pre-market trading after declining around 16% on Tuesday. Fugazi Research recently issued a report on the company.
  • Alps Group Inc (NASDAQ:ALPS) rose 9.1% to $0.71 in pre-market trading after the Malaysia-headquartered biotech announced a research collaboration targeting patient-derived organoid technology for personalized cancer care.

Losers

  • XCHG Ltd (NASDAQ:XCH) tumbled 26.7% to $0.74 in pre-market trading after jumping 52% on Tuesday.
  • TOP Financial Group Ltd (NASDAQ:TOP) fell 17.9% to $1.20 in pre-market trading. TOP Financial Group filed prospectus for offering up to 6.44 million Class A ordinary shares at $0.45645 per share.
  • Rubico Inc (NASDAQ:RUBI) fell 17.1% to $0.32 in pre-market trading after the company announced a 1-for-25 reverse stock split aimed at maintaining compliance with Nasdaq listing requirements.
  • Tianci International Inc (NASDAQ:CIIT) fell 16.7% to $0.74 in pre-market trading. Tianci International shares jumped 81% on Tuesday after the company reported a year-over-year increase in its third-quarter financial results.
  • Mobile-Health Network Solutions (NASDAQ:MNDR) fell 15% to $0.48 in pre-market trading. Mobile-Health Network Solutions announced its subsidiary, Skylink Innovations, entered into a Strategic Partnership Agreement with Contfinity to deliver a bundled offering of the OttterSG Clinic Management System and managed cybersecurity services to healthcare providers in Singapore.
  • RTB Digital Inc (NASDAQ:RTB) fell 14.8% to $10.64 in pre-market trading.
  • INLIF Ltd (NASDAQ:INLF) declined 14% to $0.048 in pre-market trading after dipping 49% on Tuesday.
  • Cerebras Systems Inc (NASDAQ:CBRS) shares dipped 13.6% to $195.78 in pre-market trading after reporting first-quarter results.
  • Spyre Therapeutics Inc (NASDAQ:SYRE) declined 9.3% to $88.00 in pre-market trading. Deutsche Bank analyst David Hoang, on Tuesday, maintained Spyre Therapeutics with a Buy and raised the price target from $115 to $135.
  • FedEx Corp (NYSE:FDX) fell 6.7% to $295.92 in pre-market trading. FedEx reported better-than-expected earnings for the fourth quarter of fiscal 2026 after the market closed on Tuesday. However, the company said operating margin in the Federal Express segment shrank to 7.7% from 8.4% a year ago.

Photo via Shutterstock